Amit Agarwal

Amit Agarwal is a Managing Director at Deloitte Consulting, overseeing the Next Generation Cell & Gene Therapy Practice on the West Coast since November 2011, having previously served as a Principal in the Life Science and Healthcare Practice at the same firm. From January 2007 to October 2011, Amit was a Partner at Scientia Advisors, focusing on growth strategies for life sciences companies across various sectors. Early career roles include Vice President at Leerink Swann & Company, Principal at A.T. Kearney, and Partner at Mitchell Madison Group, along with a diplomatic position at the US Department of State. Amit holds an MBA in Finance and Technological Innovation from MIT Sloan School of Management and has additional certifications in Arabic and Chinese Language and Area Studies from the Foreign Service Institute. An undergraduate degree in History and Pre-med was earned at Occidental College.